2,5-Dimethyl-2,5-hexanediol

We are 2,5-Dimethyl-2,5-hexanediol CAS:110-03-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 110-03-2
Product Name: 2,5-Dimethyl-2,5-hexanediol
Other Name:
2,5-Dimethyl-2,5-hexanediol
1,1,4,4-Tetramethyl-1,4-butanediol
2,5-dimethyl-5-hexanediol
2,5-dimethylhexane-2,5-diol
2,5-dimethyl-2,5-dihydroxy hexane
 
Density: 0.9±0.1 g/cm3
Boiling Point: 215.1±8.0 °C at 760 mmHg
Melting Point: 86-90 °C(lit.)
Molecular Formula: C8H18O2
Molecular Weight: 146.227
Flash Point: 126.7±0.0 °C
Exact Mass: 146.130676
PSA: 40.46000
LogP: 0.37
Vapour Pressure: 0.0±0.9 mmHg at 25°C
Index of Refraction: 1.453
Water Solubility: SOLUBLE
 
Specification
Appearance: White Crystalline Flakes
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Pyrethrins CAS: 8003-34-7.
Be used as pesticide intermediate, mainly used in the synthesis of the insecticide Pyrethrins.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,5-Dimethyl-2,5-hexanediol


Related News: An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.(2R)-3-methoxy-2-(phenylmethoxycarbonylamino)propanoic acid CAS:86096-35-7 It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.446-32-2 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.1-benzhidrilazetidin-3-amina CAS:40432-52-8 The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.

Related Products
Product Name
DL-Cysteine·HCl·H2O Cas:96998-61-7 View Details
5-Nitroisophthalic acid View Details
Isosorbide Dinitrate Cas:NO: 87-33-2 View Details
Diethyl (hydroxymethyl)phosphonate Cas:3084-40-0 manufacturer 2,5-Dimethoxytetrahydrofuran Cas:696-59-3 manufacturer Diethyl chloromalonate Cas:14064-10-9 manufacturer n-methylformamide Cas:123-39-7 manufacturer Tripeptide-3 manufacturer